Conejo-Garcia JR - Search Results

1

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, Rubin SC, Coukos G. Zhang L, et al. N Engl J Med. 2003 Jan 16;348(3):203-13. doi: 10.1056/NEJMoa020177. N Engl J Med. 2003. PMID: 12529460 Free article.

2

Letal, A tumor-associated NKG2D immunoreceptor ligand, induces activation and expansion of effector immune cells.

Conejo-Garcia JR, Benencia F, Courreges MC, Khang E, Zhang L, Mohamed-Hadley A, Vinocur JM, Buckanovich RJ, Thompson CB, Levine B, Coukos G. Conejo-Garcia JR, et al. Cancer Biol Ther. 2003 Jul-Aug;2(4):446-51. doi: 10.4161/cbt.2.4.479. Cancer Biol Ther. 2003. PMID: 14508119

3

Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28- antitumor T cells.

Conejo-Garcia JR, Benencia F, Courreges MC, Gimotty PA, Khang E, Buckanovich RJ, Frauwirth KA, Zhang L, Katsaros D, Thompson CB, Levine B, Coukos G. Conejo-Garcia JR, et al. Cancer Res. 2004 Mar 15;64(6):2175-82. doi: 10.1158/0008-5472.can-03-2194. Cancer Res. 2004. PMID: 15026360

4

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W. Curiel TJ, et al. Nat Med. 2004 Sep;10(9):942-9. doi: 10.1038/nm1093. Epub 2004 Aug 22. Nat Med. 2004. PMID: 15322536 Free article.

5

Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A.

Conejo-Garcia JR, Benencia F, Courreges MC, Kang E, Mohamed-Hadley A, Buckanovich RJ, Holtz DO, Jenkins A, Na H, Zhang L, Wagner DS, Katsaros D, Caroll R, Coukos G. Conejo-Garcia JR, et al. Nat Med. 2004 Sep;10(9):950-8. doi: 10.1038/nm1097. Epub 2004 Aug 29. Nat Med. 2004. PMID: 15334073 Free article.

6

Vascular leukocytes contribute to tumor vascularization.

Conejo-Garcia JR, Buckanovich RJ, Benencia F, Courreges MC, Rubin SC, Carroll RG, Coukos G. Conejo-Garcia JR, et al. Blood. 2005 Jan 15;105(2):679-81. doi: 10.1182/blood-2004-05-1906. Epub 2004 Sep 9. Blood. 2005. PMID: 15358628 Free article.

7

The role of dendritic cell precursors in tumour vasculogenesis.

Coukos G, Benencia F, Buckanovich RJ, Conejo-Garcia JR. Coukos G, et al. Br J Cancer. 2005 Apr 11;92(7):1182-7. doi: 10.1038/sj.bjc.6602476. Br J Cancer. 2005. PMID: 15785750 Free PMC article. Review.

8

HSV oncolytic therapy upregulates interferon-inducible chemokines and recruits immune effector cells in ovarian cancer.

Benencia F, Courrèges MC, Conejo-García JR, Mohamed-Hadley A, Zhang L, Buckanovich RJ, Carroll R, Fraser N, Coukos G. Benencia F, et al. Mol Ther. 2005 Nov;12(5):789-802. doi: 10.1016/j.ymthe.2005.03.026. Epub 2005 May 31. Mol Ther. 2005. PMID: 15925544 Free article.

9

Oncolytic HSV exerts direct antiangiogenic activity in ovarian carcinoma.

Benencia F, Courreges MC, Conejo-García JR, Buckanovich RJ, Zhang L, Carroll RH, Morgan MA, Coukos G. Benencia F, et al. Hum Gene Ther. 2005 Jun;16(6):765-78. doi: 10.1089/hum.2005.16.765. Hum Gene Ther. 2005. PMID: 15960607

10

Immunotherapy for gynaecological malignancies.

Coukos G, Conejo-Garcia JR, Roden RB, Wu TC. Coukos G, et al. Expert Opin Biol Ther. 2005 Sep;5(9):1193-210. doi: 10.1517/14712598.5.9.1193. Expert Opin Biol Ther. 2005. PMID: 16120050 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

189 results

Search Page